| 摘要 |
<p>The invention relates to the use of the beta-III spectrin gene (SPTBN2) as a biomarker for the in vitro diagnosis of cerebellar cortical degeneration, to in vitro methods of assessing the cerebellar cortical degeneration status in a canine mammal and to primers and diagnostic kits for use in said method.</p> |
